• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Research on the Impact of Supply Side Policy Collaboration of Medical Insurance on Cost Control under DIP Payment

Corresponding author: XIONG Li, xllyf@126.com
DOI: 10.12201/bmr.202406.00024
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Objective: DIP payment is an important component of Chinas medical insurance supply-side reform. This study aims to explore the synergistic effects of DIP and other medical insurance supply-side policies. Method: A city A that has piloted DIP reform was set as the treatment group, and a city B without reform was set as the control group. A total of 1,120 public medical institution samples from 2019 to 2022 were collected. The total medical expenses during hospitalization and some structural expenses were analyzed using the double difference method. Result: DIP had a significant inhibitory effect on the total medical expenses during hospitalization and the total expenses of checkups and examinations during hospitalization in city A (P<0.05), but had no impact on the total drug expenses and the total material expenses during hospitalization. Conclusion: DIP played a significant cost control role and effectively controlled the total medical expenses during hospitalization. The collaborative effects of price adjustment of medical services policy and national centralized drug/material procurement policy on cost control were insufficient. DIP synergized with other supply-side policies to promote rational medical cost structure. It is suggested that medical insurance departments should focus on the synergistic effects of medical insurance supply-side policies to jointly improve the efficiency of medical insurance fund utilization.

    Key words: DIP payment; Supply side reform; Price adjustment of medical services policy; national centralized drug/material procurement policy

    Submit time: 17 June 2024

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • xuguangjian, qiaoyukun. Research on the linkage mechanism between the adjustment of medical service price and the reform of medical insurance payment mode in China. 2021. doi: 10.12201/bmr.202104.00018

    LIN Kun-he, LIU Xiao, XIONG Ying-bei, YAO Yi-fan, XIANG Li. Exploration on the integration policies of DIP payment and total budget payment of close medical community. 2023. doi: 10.12201/bmr.202305.00002

    LIN Kun-he, LIU-Xiao, Huang Yu-meng, Huang Mei-xiang, ZHONG Zheng-dong, LI Hao, XIONG-Ying-bei, ZHOU Jin, XIANG Li. Analysis on the rush point behavior of medical institutions under the total budget of regional point method ——Take DIP payment method as an example. 2022. doi: 10.12201/bmr.202207.00022

    SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. doi: 10.12201/bmr.202303.00033

    fengyijia, zhang luying, li jiaoyang, qi yijia, chen wen. Progress and Reflections on Innovative Medical Technologies Payment Mechanism under DRG/DIP Payment in China. 2024. doi: 10.12201/bmr.202410.00024

    Tang Yuqing, Li Yinming, Chen Xizhuo, Xue Tianqin, Chen Hao. Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model. 2023. doi: 10.12201/bmr.202310.00002

    WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

    LIN Kun-he, Yao Yifan, Xiong Yingbei, XIANG Li. Analysis of the Impact Mechanism of DRG pricing and payment reform Integration Reform——Taking Quanzhou and Sanming in Fujian as examples. 2023. doi: 10.12201/bmr.202311.00001

    WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

    ZhangJingyi, GaoGuangying, HuXingyu, DengQian, ZhangDa, TianJiashuai, ZhangLiliang. A study on the implementation effect of case-based payment systems for tuberculosis patients:Based on META analysis. 2022. doi: 10.12201/bmr.202112.00012

  • ID Submit time Number Download
    1 2024-03-16

    bmr.202406.00024V1

    Download
  • Public  Anonymous  To author only

Get Citation

LIN Kun-he, YAO Yifan, XIONG Yingbei, XIONG Li. Research on the Impact of Supply Side Policy Collaboration of Medical Insurance on Cost Control under DIP Payment. 2024. biomedRxiv.202406.00024

Article Metrics

  • Read: 157
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误